Skip to main content
Premium Trial:

Request an Annual Quote

Fluidigm: Bill Colston

Fluidigm has appointed Bill Colston to its board of directors. Colston has served as president of iCarbonX since March. He joined the company as chief operating officer in April 2018 following its acquisition of his prior company. He is also on the board of iCarbonX. Prior to this, he was cofounder and CEO of HealthTell. He was also previously the scientific founder and CEO of QuantaLife, which originally developed the technlogy behind Bio-Rad's droplet digitial PCR products.

The Scan

Researchers Compare WGS, Exome Sequencing-Based Mendelian Disease Diagnosis

Investigators find a diagnostic edge for whole-genome sequencing, while highlighting the cost advantages and improving diagnostic rate of exome sequencing in EJHG.

Researchers Retrace Key Mutations in Reassorted H1N1 Swine Flu Virus With Avian-Like Features

Mutations in the acidic polymerase-coding gene boost the pathogenicity and transmissibility of Eurasian avian-like H1N1 swine influenza viruses, a PNAS paper finds.

Genome Sequences Reveal Evolutionary History of South America's Canids

An analysis in PNAS of South American canid species' genomes offers a look at their evolutionary history, as well as their relationships and adaptations.

Lung Cancer Response to Checkpoint Inhibitors Reflected in Circulating Tumor DNA

In non-small cell lung cancer patients, researchers find in JCO Precision Oncology that survival benefits after immune checkpoint blockade coincide with a dip in ctDNA levels.